NASDAQ:AKTS

Akoustis Technologies (AKTS) Stock Price, News & Analysis

$0.57
+0.01 (+1.80%)
(As of 04/25/2024 ET)
Today's Range
$0.54
$0.59
50-Day Range
$0.49
$0.79
52-Week Range
$0.45
$3.57
Volume
282,764 shs
Average Volume
821,424 shs
Market Capitalization
$55.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.92

Akoustis Technologies MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
238.8% Upside
$1.92 Price Target
Short Interest
Bearish
9.62% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.35mentions of Akoustis Technologies in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$750,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.68) to ($0.34) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.60 out of 5 stars

Computer And Technology Sector

536th out of 586 stocks

Telephone & Telegraph Apparatus Industry

10th out of 10 stocks

AKTS stock logo

About Akoustis Technologies Stock (NASDAQ:AKTS)

Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., designs, develops, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States, Asia, Europe, and internationally. It operates through Foundry Fabrication Services and RF Filters segments. The Foundry Fabrication Services segment provides engineering review and backend packaging services. Its RF Filters segment sells amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company was founded in 2013 and is headquartered in Huntersville, North Carolina.

AKTS Stock Price History

AKTS Stock News Headlines

7 Penny Stocks if You Believe Lady Luck’s on Your Side
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
7 Penny Stocks if You Believe Lady Luck's on Your Side
Thousands of investors use this no cost solution | Do you?
In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.
Akoustis, Inc.: Akoustis Reports Second Quarter FY24 Results
Akoustis Reports Second Quarter FY24 Results
A Preview Of Akoustis Technologies's Earnings
Akoustis Technologies Inc AKTS
Akoustis Technologies Founder Acquires 144% More Stock
See More Headlines
Receive AKTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akoustis Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2024
Today
4/25/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Telephone & telegraph apparatus
Sub-Industry
N/A
Current Symbol
NASDAQ:AKTS
Fax
N/A
Employees
222
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.92
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+239.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-63,560,000.00
Net Margins
-232.77%
Pretax Margin
-240.81%

Debt

Sales & Book Value

Annual Sales
$27.12 million
Book Value
$1.20 per share

Miscellaneous

Free Float
93,081,000
Market Cap
$55.71 million
Optionable
Optionable
Beta
1.71
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

AKTS Stock Analysis - Frequently Asked Questions

Should I buy or sell Akoustis Technologies stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AKTS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKTS, but not buy additional shares or sell existing shares.
View AKTS analyst ratings
or view top-rated stocks.

What is Akoustis Technologies' stock price target for 2024?

3 Wall Street analysts have issued 12 month price objectives for Akoustis Technologies' shares. Their AKTS share price targets range from $1.00 to $3.00. On average, they anticipate the company's stock price to reach $1.92 in the next twelve months. This suggests a possible upside of 238.8% from the stock's current price.
View analysts price targets for AKTS
or view top-rated stocks among Wall Street analysts.

How have AKTS shares performed in 2024?

Akoustis Technologies' stock was trading at $0.8340 at the beginning of the year. Since then, AKTS shares have decreased by 32.2% and is now trading at $0.5658.
View the best growth stocks for 2024 here
.

When is Akoustis Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our AKTS earnings forecast
.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) issued its quarterly earnings data on Tuesday, February, 13th. The technology company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.18) by $0.01. The technology company had revenue of $7.02 million for the quarter, compared to the consensus estimate of $6.99 million. Akoustis Technologies had a negative net margin of 232.77% and a negative trailing twelve-month return on equity of 80.80%. During the same quarter last year, the company earned ($0.19) EPS.

What guidance has Akoustis Technologies issued on next quarter's earnings?

Akoustis Technologies updated its third quarter 2024 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $8.7 million-$9.2 million, compared to the consensus revenue estimate of $8.5 million.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Block (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Taylor Frigon Capital Management LLC (3.41%). Insiders that own company stock include Arthur Geiss, David Aichele, James Michael Mcguire, Jeffrey B Shealy, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends
.

How do I buy shares of Akoustis Technologies?

Shares of AKTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AKTS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners